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Abbreviations
The percentage of liver transplantations over the last two decades has been on the rise across the world, nearly 33000 reported 
transplants took place in 2017 with an increase expected in the upcoming years. Majority of the recipients of liver transplant gen-
erally has liver cirrhosis caused by NAFLD/AFLD making them vulnerable to damage their other organs as well. In most cases the 
transplantation organ is donated by a blood relative within the family as most other donors have high chances of graft rejection. We 
report a case of liver cirrhosis patient with continuously liver function tests carried out for a period of three months, subsequently 
the patient was listed as one of the recipients for liver transplant as his biochemical parameters showed signs of liver failure pro-
gressing to severe state.
Introduction
NAFLD: Non-alcoholic Fatty Liver Disease; AFLD: Alcoholic Fatty 
Liver Disease; ESLD: End-stage Liver Disease; e-GFR: Estimated 
Glomerular Filtration Rate; CKD: Chronic Kidney Disease.
Liver diseases cause nearly 2 million deaths worldwide and 
one of the leading causes of non-communicable diseases (NCD’s) 
[1]. Non-alcoholic fatty liver disease (NAFLD), alcoholic fatty liver 
disease (AFLD), hepatocellular carcinoma and viral hepatitis have 
been identified as the main types of liver diseases presently evident 
globally. Liver cirrhosis leads to end-stage liver disease (ESLD) 
which can lead to complications such as ascites, hepatic encepha-
lopathy, spontaneous bacterial peritonitis, and esophageal varices 
making the quality of life even harder in these individuals [2].
In Sri Lanka liver disease is the second leading cause of death 
in the in-patient care system and averages nearly 15 deaths per 
100,000 in the country [3]. With the increasing presence of diabe-
tes and obesity in the country, NAFLD has become the main form of 
liver disease leading to liver cirrhosis, additionally this also triggers 
damage to the kidneys resulting in kidney failure as well [4]. 
Liver function tests, ultrasound and blood profiling are the com-
mon tests carried out to diagnose the patient, in some instances a 
liver biopsy is taken to confirm the cause of the liver disease. Pa-
tients in end stage liver disease will require transplantation of a 
healthy donor as the medications provided will only allow them to 
get through the day rather than helping them solve the dilemma. 
Organ transplantation is a major issue as organ shortage has 
been known to be a global phenomenon, living donors have high 
chances of successfully providing the liver has the chances of rejec-
tion are lower compared to the non-living [5]. With the uncertainty 
of liver availability for the recipients affected individuals and their 
families seek for alternative options and find organs from the “black 
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market” or bribe physicians to obtain the liver for transplantation. 
Till date organ trafficking still takes place across continents with 
the public paying a high sum of money to obtain the desired organ, 
this is mainly due to the fact that most countries have a shortage 
in organ supply resulting in an alternative pathway being formed 
[6,7]. 
In this paper we present a case of a patient who is seeking for 
a donor for liver transplantation in Sri Lanka, the purpose of this 
study is to show the early detection methods we can use by con-
ducting a series of liver function tests that would assist in helping 
us identify the condition of the patient early to list him under the 
liver transplantation list registry. Moreover, we describe the chang-
es in the liver function tests carried out on a monthly basis and 
other symptoms presented by the patient. 
Case Report
A 64-year-old male with liver cirrhosis presented with consis-
tent pain around the abdomen region and complained of frequent 
pale-yellow urination. There was no significant past medical histo-
ry and family members are healthy. On initial diagnosis, the serum 
electrolytes profile was conducted. Serum sodium levels were at 
122.0 mmol/L and chloride levels were at 87 mmol/L, these were 
flagged as low values at the investigations. 
A complete blood count was ordered based on the results ob-
tained from the electrolyte levels, the lymphocytes level were at 
6.8%, total white cell count at 11.9 cells/L, hemoglobin at 9.2 g/dL, 
red blood cells count at 3.01 cells/L, hematocrit at 27.1%, platelet 
count at 90 X 109/L and c-reactive protein levels at 4.1 mg/L. 
Liver profile conducted indicated low total protein levels (47.9 
g/L), albumin levels were at 22.6 g/L, total bilirubin were at 5.18 
mg/dL and alkaline phosphatase was at 316.0 U/L, AST at 21.5 U/L 
and ALT at 23.5 U/L. Bilirubin test indicated an elevation of total 
bilirubin at 6.35 mg/dL and direct bilirubin at 4.32 mg/dL. To as-
sess the function of the kidneys a serum creatinine profile was car-
ried out to understand the implications caused by liver damage, 
the serum creatinine enzymatic levels were at 1.18 mg/dL and the 
e-GFR level at 65 ml/min/1.73m2. A urine test was conducted with 
pale yellow urine color observed with slightly turbid in appear-
ance, bilirubin was positive in the report and erythrocyte sedimen-
tation rate at 17 MM for the first hour.
Ultrasound scans revealed enlargement of the right and left 
lobes and the spleen, to confirm this a CT Scan of the abdomen was 
carried out. Irregular shape and shrunken right lobe were found 
to be presented by the individual, enlargement of the spleen was 
evident at 12cm. There was no evidence to show damage caused 
to the kidneys or urinary tract. A mild increase in the interstitial 
thickening of the bilateral lung bases were observed as well. A di-
agnosis of cirrhotic liver and cholelithiasis was made based on the 
findings in the CT scans.
Figure 1: Scan results of the abdomen.
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Figure 2: Endoscopy results indicated hypertensive gastropathy.
Discussion and Conclusion
Liver cirrhosis is the end stage condition of liver disease caused 
by various types of liver diseases most commonly due to NAFLD or 
AFLD. Hepatitis B has been identified as the common cause of the 
disease in the Asia-Pacific region, nevertheless in the case of Sri 
Lanka the main cause has been identified to be AFLD/NAFLD [8,9].
Cirrhosis is a result of various multifactorial factors resulting in 
necroinflammation and distortion of the hepatic vascular architec-
ture is a common histological observation made by histopatholo-
gists globally [10]. A reported 56 million deaths were caused by 
NCD’s in 2016 and liver disease was one of the leading causes of 
deaths, mainly people from the 3rd to 7th decade are generally af-
fected by the disease [11]. Patients suffering from liver cirrhosis 
generally increases the malnutrition and chances of other diseases 
such as chronic kidney disease and weight loss to occur in individ-
uals [12]. Most the cases of liver diseases are asymptomatic until 
it reaches the stage of liver cirrhosis making it hard for early di-
agnosis, sepsis, encephalopathy and jaundice have been the main 
symptoms presented by the patients. The only option for patients 
once they reach end stage of liver cirrhosis is to undergo a liver 
transplantation before the condition worsens. According to a study 
conducted by Middleton [13], only 25% of the transplantations 
have no graft rejection as most donors are not compatible for the 
recipients. Due to the limitations and availability of the organ for 
transplantation the rates or mortality due to liver diseases has in-
creased [14]. 
In order for successful transplantation to occur several tests 
needs to be conducted prior to being listed on the registry list as 
a recipient. The patient suffering from liver cirrhosis had no prior 
history of any other medical condition and no family history of the 
disease, with increasing signs and symptoms of liver disease be-
ing presented he was presented to the physician who conducted a 
series of tests to confirm the diagnosis. 
Serum electrolytes level have shown early indication of liver cir-
rhosis, hyponatremia is the most common electrolyte abnormality 
observed in end-stage liver disease. The patient shows signs of hy-
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ponatremia with sodium levels below 130 mmol/L [15], addition-
ally the overall chloride levels are also below the normal range at 
87 mmol/L indicating the loss of salt in the body causing disrup-
tion in the ion channels [16]. 
e-GFR test was carried out to identify if there are any damages 
caused to the kidneys as studies have shown that electrolyte levels 
could fluctuate due to the damage caused to the kidneys [17]. To 
confirm the presence of liver disease a function test was performed 
with elevated bilirubin levels indicating that the patient has liver 
disease resulting of bilirubin in the blood, moreover the pre-exist-
ing condition of jaundice was supported by the elevated levels [18]. 
A urine test was performed to assess the overall extend of the dam-
age, with bilirubin being positive and clear urine detected in the 
test the patient was administered with a mixture of corticosteroids 
and chelating agents combined. 
Imaging tests were performed a week after the administration 
of drugs with an ultrasound scan being performed first as it is the 
most common method used among in-patient care hospitals. Irreg-
ular shaped liver and right lobes indicated signs of NAFLD in the 
patient and enlargement of the spleen was evidently visible [19]. 
CT-scan confirmed the diagnosis of liver cirrhosis with cholelithia-
sis formation which disrupted the liver and caused tissue scarring 
to take place. 
The overall prognosis of the patient is poor with progressive 
liver failure observed in the patient over a period of 3 months. By 
carrying out step wise series of testing we were able to identify 
the cause of liver disease and the extent of damage caused in the 
patient, this method is an easy and fast way of diagnosing patients 
with liver cirrhosis and would potentially save precious time in 
identifying a suitable donor for transplantation. 
In conclusion, liver transplantation processes generally take 
long time in identifying the suitable donor and recipient due to the 
lack of early testing and identification of availability of the organ in 
the country. With continuous testing performed on a regular time 
interval we can identify potential donors in a quicker and more re-
liable manner limiting the number of deaths caused by failure of 
liver transplantations in the future. 
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Appendix
Test Result Unit Reference value
Serum sodium 122.0 mmol/L 136.0 - 146.0
Serum potassium 4.10 mmol/L 3.5 - 5.1
Serum chloride 87 mmol/L 101.0 - 109.0
Table 1: Serum electrolyte levels.
Test Result Unit Reference value
Bilirubin - total 6.35 mg/dL 0.1 - 1.2
Bilirubin - direct 4.32 mg/dL 0.1 - 0.5
Bilirubin - indirect 2.03 mg/dL
Table 2: Bilirubin test.
Test Result Unit Reference value
Total protein 47.9 g/L 60.0 - 83.0
Albumin 22.6 g/L 35.0 - 50.0
Globulin 25.3 g/L 25.0 - 33.0
A/G ratio 0.9 0.8 - 2.3
Bilirubin-total 5.18 mg/dL 0.1 - 1.2
ALK.PHOS 316.0 U/L 98.0 - 258.0
ALT 21.5 U/L 0.1 - 40.0
AST 23.5 U/L 0.1 - 40.0
GAMMA-GT 11.6 U/L 0.1 - 49.0
Table 3: Liver function test.
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